Meridian Bioscience (VIVO) Reports In-Line Q2 EPS, Beats on Revenues; Boosts FY18 EPS Outlook
Go back to Meridian Bioscience (VIVO) Reports In-Line Q2 EPS, Beats on Revenues; Boosts FY18 EPS Outlook| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 5.97 +0.52 (9.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.45 | 52 Week High | $21.49 | |||
| Open | $5.51 | 52 Week Low | $15.75 | |||
| Day High | $6.24 | P/E | 6.78 | |||
| Day Low | $5.35 | EPS | $0.88 | |||
| Volume | 1,104,159 | |||||
